| Dr Imad Shawa, MD | |
|
701 E County Line Road, Suite 101, Greenwood, IN 46143-1070 | |
| (317) 885-2334 | |
| (317) 885-2869 |
| Full Name | Dr Imad Shawa |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 38 Years |
| Location | 701 E County Line Road, Greenwood, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659341741 | NPI | - | NPPES |
| 200511510 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Health Indianapolis | Indianapolis, IN | Hospital |
| Franciscan Health Mooresville | Mooresville, IN | Hospital |
| Major Hospital | Shelbyville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Francis Medical Group Llc | 7012067697 | 112 |
| Indiana Internal Medicine Consultants Llc | 7911899489 | 41 |
News Archive
Mylan Inc. today confirmed that the company has been sued by Vivelle Ventures LLC, Noven Pharmaceuticals Inc. and Novartis Pharmaceuticals Corporation in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Estradiol Transdermal System, USP (Twice-Weekly), 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day.
The study found that smoking is responsible for a quarter of head and neck cancers among individuals who do not drink alcohol.
As the World Bank meetings begin, a new study shows that investments in adolescent health and wellbeing are some of the best that can be made towards achieving the SDGs
Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Capsules, 15 mg and 25 mg.
India's Tata Group on Monday "unveiled a new low-cost water purifier, which it hopes will provide safe drinking water for millions and cut the toll of deadly diseases," Agence France-Presse/mysinchew.com reports.
› Verified 5 days ago
| Entity Name | Indiana Internal Medicine Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609834357 PECOS PAC ID: 7911899489 Enrollment ID: O20040329000685 |
News Archive
Mylan Inc. today confirmed that the company has been sued by Vivelle Ventures LLC, Noven Pharmaceuticals Inc. and Novartis Pharmaceuticals Corporation in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Estradiol Transdermal System, USP (Twice-Weekly), 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day.
The study found that smoking is responsible for a quarter of head and neck cancers among individuals who do not drink alcohol.
As the World Bank meetings begin, a new study shows that investments in adolescent health and wellbeing are some of the best that can be made towards achieving the SDGs
Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Capsules, 15 mg and 25 mg.
India's Tata Group on Monday "unveiled a new low-cost water purifier, which it hopes will provide safe drinking water for millions and cut the toll of deadly diseases," Agence France-Presse/mysinchew.com reports.
› Verified 5 days ago
| Entity Name | St Francis Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467693135 PECOS PAC ID: 7012067697 Enrollment ID: O20090603000310 |
News Archive
Mylan Inc. today confirmed that the company has been sued by Vivelle Ventures LLC, Noven Pharmaceuticals Inc. and Novartis Pharmaceuticals Corporation in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Estradiol Transdermal System, USP (Twice-Weekly), 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day.
The study found that smoking is responsible for a quarter of head and neck cancers among individuals who do not drink alcohol.
As the World Bank meetings begin, a new study shows that investments in adolescent health and wellbeing are some of the best that can be made towards achieving the SDGs
Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Capsules, 15 mg and 25 mg.
India's Tata Group on Monday "unveiled a new low-cost water purifier, which it hopes will provide safe drinking water for millions and cut the toll of deadly diseases," Agence France-Presse/mysinchew.com reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Imad Shawa, MD 701 E County Line Road, Suite 101, Greenwood, IN 46143-1070 Ph: (317) 885-2334 | Dr Imad Shawa, MD 701 E County Line Road, Suite 101, Greenwood, IN 46143-1070 Ph: (317) 885-2334 |
News Archive
Mylan Inc. today confirmed that the company has been sued by Vivelle Ventures LLC, Noven Pharmaceuticals Inc. and Novartis Pharmaceuticals Corporation in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Estradiol Transdermal System, USP (Twice-Weekly), 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day.
The study found that smoking is responsible for a quarter of head and neck cancers among individuals who do not drink alcohol.
As the World Bank meetings begin, a new study shows that investments in adolescent health and wellbeing are some of the best that can be made towards achieving the SDGs
Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Capsules, 15 mg and 25 mg.
India's Tata Group on Monday "unveiled a new low-cost water purifier, which it hopes will provide safe drinking water for millions and cut the toll of deadly diseases," Agence France-Presse/mysinchew.com reports.
› Verified 5 days ago
Dr. Michael B Dubois, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2860 Fax: 317-885-2869 | |
Dr. Cary Zietlow, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 45 N Madison Ave, Greenwood, IN 46142 Phone: 317-887-7624 Fax: 317-887-7625 | |
Dr. Abhinav Singh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2860 Fax: 317-885-2869 | |
Dr. John Robert Colaluca, D.O Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 898 E Main St, Greenwood, IN 46143 Phone: 317-887-1348 Fax: 317-882-1631 | |
Edris Ayoubi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2860 Fax: 317-885-2869 | |
Walid Samaan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1040 Sierra Dr, Suite 400, Greenwood, IN 46143 Phone: 317-528-4270 Fax: 317-865-8336 | |
Dr. Ruxandra C Ionescu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2334 Fax: 317-885-2869 |